Overactive bladder - pharmacological treatment

Rev Assoc Med Bras (1992). 2019 May 2;65(4):487-492. doi: 10.1590/1806-9282.65.4.487.

Abstract

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.

Publication types

  • Practice Guideline

MeSH terms

  • Acetanilides / administration & dosage*
  • Adrenergic beta-3 Receptor Agonists / administration & dosage*
  • Antidepressive Agents / administration & dosage
  • Benzilates / administration & dosage
  • Benzofurans / administration & dosage
  • Brazil
  • Clinical Decision-Making
  • Drug Therapy, Combination
  • Humans
  • Mandelic Acids / administration & dosage
  • Muscarinic Antagonists / administration & dosage*
  • Nortropanes / administration & dosage
  • Pyrrolidines / administration & dosage
  • Solifenacin Succinate / administration & dosage
  • Thiazoles / administration & dosage*
  • Tolterodine Tartrate / administration & dosage
  • Urinary Bladder, Overactive / drug therapy*

Substances

  • Acetanilides
  • Adrenergic beta-3 Receptor Agonists
  • Antidepressive Agents
  • Benzilates
  • Benzofurans
  • Mandelic Acids
  • Muscarinic Antagonists
  • Nortropanes
  • Pyrrolidines
  • Thiazoles
  • trospium chloride
  • Tolterodine Tartrate
  • darifenacin
  • oxybutynin
  • Solifenacin Succinate
  • mirabegron